BRCA1 and RAD51C promoter hypermethylation confer...

Gynecologic Oncology 2017 / 06 Vol. 145

BRCA1 and RAD51C promoter hypermethylation confer sensitivity to the PARP inhibitor rucaparib in patients with relapsed, platinum-sensitive ovarian carcinoma in ARIEL2 Part 1

Swisher, E.M., Harrell, M.I., Lin, K., Coleman, R.L., Konecny, G.E., Tinker, A.V., O'Malley, D.M., McNeish, I., Kaufmann, S.H.
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
145
Language:
english
Journal:
Gynecologic Oncology
DOI:
10.1016/j.ygyno.2017.03.034
Date:
June, 2017
File:
PDF, 120 KB
english, 2017
Conversion to is in progress
Conversion to is failed